BIOMAT Database Logo BIOMAT Database Logo

Methylenetetrahydrofolate reductase mutation and coronary artery disease. 1996

R Narang, and G Callaghan, and A W Haider, and G J Davies, and E G Tuddenham

UI MeSH Term Description Entries
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D003327 Coronary Disease An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels. Coronary Heart Disease,Coronary Diseases,Coronary Heart Diseases,Disease, Coronary,Disease, Coronary Heart,Diseases, Coronary,Diseases, Coronary Heart,Heart Disease, Coronary,Heart Diseases, Coronary
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000587 Oxidoreductases Acting on CH-NH Group Donors Enzymes catalyzing the dehydrogenation of secondary amines, introducing a C Secondary Amine Oxidoreductases,Amine Oxidoreductases, Secondary Amine,Amine Oxidoreductases, Secondary,Oxidoreductases Acting on CH NH Group Donors,Oxidoreductases, Secondary Amine
D042965 Methylenetetrahydrofolate Reductase (NADPH2) A flavoprotein amine oxidoreductase that catalyzes the reversible conversion of 5-methyltetrahydrofolate to 5,10-methylenetetrahydrofolate. This enzyme was formerly classified as EC 1.1.1.171. Methylene-THF Reductase (NADPH),5,10-Methylenetetrahydrofolate Reductase (NADPH),Methylene Tetrahydrofolate Reductase,Methylenetetrahydrofolate Reductase,Methylenetetrahydrofolate Reductase (NADPH),Tetrahydrofolate Reductase, Methylene

Related Publications

R Narang, and G Callaghan, and A W Haider, and G J Davies, and E G Tuddenham
Methylenetetrahydrofolate reductase mutation and coronary artery disease.
January 1998, Circulation,
R Narang, and G Callaghan, and A W Haider, and G J Davies, and E G Tuddenham
Methylenetetrahydrofolate reductase (MTHFR) mutation, homocyst(e)ine, and coronary artery disease.
October 1997, Circulation,
R Narang, and G Callaghan, and A W Haider, and G J Davies, and E G Tuddenham
Methylenetetrahydrofolate reductase gene and coronary artery disease.
April 2000, Circulation,
R Narang, and G Callaghan, and A W Haider, and G J Davies, and E G Tuddenham
Methylenetetrahydrofolate reductase gene and coronary artery disease.
January 1997, Circulation,
R Narang, and G Callaghan, and A W Haider, and G J Davies, and E G Tuddenham
Thermolabile methylenetetrahydrofolate reductase in coronary artery disease.
October 1997, Circulation,
R Narang, and G Callaghan, and A W Haider, and G J Davies, and E G Tuddenham
Methylenetetrahydrofolate Reductase Polymorphism and Premature Coronary Artery Disease.
June 2019, Cureus,
R Narang, and G Callaghan, and A W Haider, and G J Davies, and E G Tuddenham
Multiple coronary artery thrombosis in 5,10-methylenetetrahydrofolate reductase gene mutation.
January 2011, Cardiology research and practice,
R Narang, and G Callaghan, and A W Haider, and G J Davies, and E G Tuddenham
Methylenetetrahydrofolate reductase genotypes and early-onset coronary artery disease.
December 1999, Circulation,
R Narang, and G Callaghan, and A W Haider, and G J Davies, and E G Tuddenham
Methylenetetrahydrofolate reductase polymorphism (C-677T) and coronary artery disease.
September 1998, Clinical science (London, England : 1979),
R Narang, and G Callaghan, and A W Haider, and G J Davies, and E G Tuddenham
Effect of common methylenetetrahydrofolate reductase gene mutation on coronary artery disease in familial hypercholesterolemia.
October 2000, The American journal of cardiology,
Copied contents to your clipboard!